Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2002;105:1509-1510
doi: 10.1161/hc1202.105940
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baim, D.
Right arrow Articles by Wasserman, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baim, D.
Right arrow Articles by Wasserman, B.
Related Collections
Right arrow Pathophysiology
Right arrow Arterial thrombosis
Right arrow Acute coronary syndromes
Right arrow CT and MRI
Right arrow Computerized tomography and Magnetic Resonance Imaging

(Circulation. 2002;105:1509.)
© 2002 American Heart Association, Inc.

Thoughts on the Role of the Healing Professions and the Events of September 11, 2001

Donald Baim, MD, Boston, Mass; Thomas J. Brady, MD, Boston, Mass; S. Ward Casscells, MD, Houston, Tex; Michael Dunne, MD, Groton, Conn; Zahi Fayad, PhD, New York, NY; Valentin Fuster, MD, New York, NY, Conference Co-Director; Scott Gazelle, MD MPH, PhD, Boston, Mass; Alan Heldman, MD, Baltimore, Md; Thomas Hatsukami, MD, Seattle, Wash; Scott Kinlay, MD, Boston, Mass; Antoine Lafont, MD PhD, Paris, France; Richard Lee, MD, Boston, Mass; Peter Libby, MD, Boston, Mass, Conference Co-Director; Bernhard Meier, MD, Bern, Switzerland; James E. Muller, MD, Boston, Mass, Conference Co-Director; Morteza Naghavi, MD, Houston, Tex; Christopher O’Donnell, MD, Boston, Mass; Emerson Perin, MD, Houston, Tex; Mark Rekhter, PhD, Ann Arbor, Mich; John Rumberger, MD PhD, Dublin, Ohio; Mary Russell, MD, Natick, Mass; Robert Schwartz, MD, Rochester, Minn; Andrew Selwyn, MD, Boston, Mass; H. William Strauss, MD, Stanford, Calif; Gary Tearney, MD PhD, Boston, Mass; Takanobu Tomaru, MD, Tokyo, Japan; E. Muran Tuzcu, MD, Cleveland, Ohio; Bruce Wasserman, MD, Baltimore, Md

Speakers for the Vulnerable Plaque Conference

On October 5 and 6, 2001, less than a month after the terrorist attacks on the United States, a conference on the Pathophysiology, Detection, and Treatment of Vulnerable Plaque was held in Boston, Mass. Nineteen scientists from around the world came together, despite the uncertainty of air travel, to continue the work against this important cause of cardiovascular disease. After the faculty dinner, Dr James Muller, Co-Director of the Vulnerable Plaque Program of the Center for the Integration of Medicine and Innovative Technology (CIMIT) and Director of Clinical Research in Cardiology at the Massachusetts General Hospital and Harvard Medical School, offered the following thoughts on cardiovascular research and the September 11, 2001, terrorist attacks. Dr Muller was one of the co-founders of International Physicians for Prevention of Nuclear War, the organization awarded the 1985 Nobel Peace Prize.

The terrible violence of September 11, a day of mass murder of innocent civilians, had many consequences, some of which directly affected our collective effort to prevent death from vulnerable plaque.

Specifically, I refer to the irony that September 11 started as a day to celebrate progress for the vulnerable plaque research community. Over 10 000 individuals congregated at the Transcatheter Cardiovascular Therapeutics (TCT) Conference in Washington, DC. The program included a town meeting on vulnerable plaque, one of those wonderful occasions when the scientists working in isolation come together to share progress and ideas. The event was a rare moment when one could actually feel a massive human problem slowly giving way to organized, dedicated human effort.

At 8:00 AM, I gave the opening lecture, which included an overview of the topic of vulnerable and invulnerable plaques.

At 8:45, while Dr Peter Fitzgerald described the use of ultrasound and OCT for the diagnosis and treatment of vulnerable plaque, the first plane hit the North Tower.

At 9:03, as Dr Mort Naghavi, who is here tonight, reported a novel method for MR imaging of macrophages, the second plane hit the South Tower.

At 9:43, as our panel discussion began, the third plane hit the Pentagon, less than 2 miles away.

At 10:05, the South Tower collapsed.

At 10:10, the hijackers on Flight 93, which was apparently headed for Washington, were foiled by American heroes.

At 10:28, the North Tower collapsed, and the death toll for that terrible morning exceeded . . . [Full Text of this Article]